Search
for
Sort by
Research 31–60 of 154
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Dermatology of androgen-related disorders
- Androgenic Effects on Ventricular Repolarization
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Idiopathic Hirsutism*
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Obesity and the Polycystic Ovary Syndrome
- Hormonal therapies for acne
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Hormone therapy in acne
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- CLINICAL UPDATES IN HAIR
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Alopecia - the search for novel agents continues
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Androgen excess and post-reproductive health
- Hirsutism
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Physiology and Medical Treatments for Alopecia
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)